Jan 18 (Reuters) - JW (Cayman) Therapeutics Co Ltd
2126.HK :
* MEDIGENE RECEIVES $3 MILLION MILESTONE PAYMENT FROM
2SEVENTY BIO
* MEDIGENE AG - MILESTONE PAYMENT IS RELATED TO
ESTABLISHMENT OF
2SEVENTY BIO'S STRATEGIC PARTNERSHIP WITH JW THERAPEUTICS
* MEDIGENE AG - PAYMENT PROVIDES FURTHER VALIDATION OF
MEDIGENE'S
END-TO-END PLATFORM
* MEDIGENE AG - PAYMENT DOES NOT ALTER GUIDANCE ON CASH
RUNWAY OF
MEDIGENE, WHICH BASED ON CURRENT PLANNING, REMAINS INTO Q4 2024
Source text for Eikon: ID:nGNX9DSycx
Further company coverage: 2126.HK
((Reuters.Briefs@thomsonreuters.com;))